Author:
Xiang Jinbao,Li Hanghang,Yang Kai,Yi Lang,Xu Yongnan,Dang Qun,Bai Xu
Publisher
Springer Science and Business Media LLC
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Drug Discovery,Molecular Biology,General Medicine,Information Systems,Catalysis
Reference29 articles.
1. Horton DA, Bourne GT, Smythe ML (2003) The combinatorial synthesis of bicyclic privileged structures or privileged substructures. Chem Rev 103: 893–930. doi: 10.1021/cr020033s
2. Gangjee A, Lin X, Queener SF (2004) Design, synthesis, and biological evaluation of 2,4-diamino-5-methyl-6-substituted-pyrrolo[2,3-d]pyrimidines as dihydrofolate reductase inhibitors. J Med Chem 47: 3689–3692. doi: 10.1021/jm0306327
3. Curtin NJ, Barlow HC, Bowman KJ, Calvert AH, Davison R, Golding BT, Huang B, Loughlin PJ, Newell DR, Smith PG, Griffin RJ (2004) Resistance-modifying agents. 11. Pyrimido[5,4-d]pyrimidine modulators of antitumor drug activity. Synthesis and structure-activity relationships for nucleoside transport inhibition and binding to α1-acid glycoprotein. J Med Chem 47: 4905–4922. doi: 10.1021/jm040772w
4. Cossrow J, Guan B, Ishchenko A, Jones JH, Kumaravel G, Lugovskoy A, Peng H, Powell N, Raimundo BC, Tanaka H, Vessels J, Wynn T, Xin Z (2009) Heterocyclic compounds useful as RAF kinase inhibitors. Patent US20090005359
5. Dehnhardt CM, Venkatesan AM, Santos ED, Chen Z, Santos O, Ayral-Kaloustian S, Brooijmans N, Mallon R, Hollander I, Feldberg L, Lucas J, Chaudhary I, Yu K, Gibbons J, Abraham R, Mansour TS (2010) Lead optimization of N-3-substituted 7-morpholinotriazolopyrimidines as dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitors: discovery of PKI-402. J Med Chem 53: 798–810. doi: 10.1021/jm9014982
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献